↓ Skip to main content

PLOS

Isolation and Characterization of Antimicrobial Compounds in Plant Extracts against Multidrug-Resistant Acinetobacter baumannii

Overview of attention for article published in PLOS ONE, April 2013
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
3 Facebook pages
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
157 Mendeley
Title
Isolation and Characterization of Antimicrobial Compounds in Plant Extracts against Multidrug-Resistant Acinetobacter baumannii
Published in
PLOS ONE, April 2013
DOI 10.1371/journal.pone.0061594
Pubmed ID
Authors

Yoko Miyasaki, John D. Rabenstein, Joshua Rhea, Marie-Laure Crouch, Ulla M. Mocek, Patricia Emmett Kittell, Margie A. Morgan, Wesley Stephen Nichols, M. M. Van Benschoten, William David Hardy, George Y. Liu

Abstract

The number of fully active antibiotic options that treat nosocomial infections due to multidrug-resistant Acinetobacter baumannii (A. baumannii) is extremely limited. Magnolia officinalis, Mahonia bealei, Rabdosia rubescens, Rosa rugosa, Rubus chingii, Scutellaria baicalensis, and Terminalia chebula plant extracts were previously shown to have growth inhibitory activity against a multidrug-resistant clinical strain of A. baumannii. In this study, the compounds responsible for their antimicrobial activity were identified by fractionating each plant extract using high performance liquid chromatography, and determining the antimicrobial activity of each fraction against A. baumannii. The chemical structures of the fractions inhibiting >40% of the bacterial growth were elucidated by liquid chromatography/mass spectrometry analysis and nuclear magnetic resonance spectroscopy. The six most active compounds were identified as: ellagic acid in Rosa rugosa; norwogonin in Scutellaria baicalensis; and chebulagic acid, chebulinic acid, corilagin, and terchebulin in Terminalia chebula. The most potent compound was identified as norwogonin with a minimum inhibitory concentration of 128 µg/mL, and minimum bactericidal concentration of 256 µg/mL against clinically relevant strains of A. baumannii. Combination studies of norwogonin with ten anti-Gram negative bacterial agents demonstrated that norwogonin did not enhance the antimicrobial activity of the synthetic antibiotics chosen for this study. In conclusion, of all identified antimicrobial compounds, norwogonin was the most potent against multidrug-resistant A. baumannii strains. Further studies are warranted to ascertain the prophylactic and therapeutic potential of norwogonin for infections due to multidrug-resistant A. baumannii.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Canada 1 <1%
Unknown 155 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 15%
Student > Ph. D. Student 18 11%
Student > Master 17 11%
Researcher 16 10%
Student > Doctoral Student 10 6%
Other 23 15%
Unknown 50 32%
Readers by discipline Count As %
Agricultural and Biological Sciences 31 20%
Biochemistry, Genetics and Molecular Biology 18 11%
Chemistry 13 8%
Immunology and Microbiology 12 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Other 16 10%
Unknown 57 36%